Cargando…

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers

BACKGROUND: The changes and correlations of TRAIL (TNF-related apoptosis-inducing-ligand) and CXCL8 (IL8) prior to treatment and three months following therapy as well as the corresponding Positron emission tomography (PET/CT) (SUVmax: standardized uptake maximum values) results were evaluated. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celik, Betül, Yalcin, Arzu Didem, Bisgin, Atil, Dimitrakopoulou-Strauss, Antonia, Kargi, Aysegül, Strauss, Ludwig G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808407/ https://www.ncbi.nlm.nih.gov/pubmed/24145180 http://dx.doi.org/10.12659/MSM.889605

Ejemplares similares

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Mechanisims of asthma and allergic disease - 1088. Increased serum strail level in newly diagnosed stave-iv lung adenocarcinoma but not sqamous cell carcinoma, is correlated with age and smoking
por: Kargi, Aysegul, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
por: Bisgin, Atil, et al.
Publicado: (2012)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

233 The Evaluation of Allergen Sensitivity in Allergic Rhinoconjunctivitis and Allergic Asthma Patients in Antalya, Turkey
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

384 Jessner-kanoff Lymphocytic Infiltrate as a Side Effect of Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

IL-8, IL-10, TGF-β, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment
por: Yalcin, Arzu D., et al.
Publicado: (2012)

Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
por: Yalcin, Ata Nevzat, et al.
Publicado: (2015)

2-Deoxy-2-fluoro-d-glucose metabolism in Arabidopsis thaliana
por: Fatangare, Amol, et al.
Publicado: (2015)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone
por: Uzun, Rusen, et al.
Publicado: (2016)

6-Deoxy-6-fluoro-d-galactose
por: Jenkinson, Sarah F., et al.
Publicado: (2010)

1-Deoxy-1-fluoro-l-galactitol
por: Jenkinson, Sarah F., et al.
Publicado: (2010)

Evaluation of sOX-2 levels in type2 diabetic foot and nephropathic patients: association with disease activity
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Radiotherapeutic use of 2-deoxy-2-[(18)F]fluoro-D-glucose – a comment
por: Meyer, Michael Andrew
Publicado: (2004)

[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)

Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
por: Jirka, Silvana M G, et al.
Publicado: (2015)

Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates
por: Janas, Maja M, et al.
Publicado: (2019)

Correlation of Dynamic PET and Gene Array Data in Patients with Gastrointestinal Stromal Tumors
por: Strauss, Ludwig G., et al.
Publicado: (2012)

Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose
por: Penna, Patricia Sola, et al.
Publicado: (2023)

Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: Association with disease activity
por: Arik, Hasan Onur, et al.
Publicado: (2014)

Applications of 2-deoxy-2-fluoro-D-glucose (FDG) in Plant Imaging: Past, Present, and Future
por: Fatangare, Amol, et al.
Publicado: (2016)

Synthesis of 4′-Substituted-2′-Deoxy-2′-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents
por: Kasthuri, Mahesh, et al.
Publicado: (2020)

Metabolic and Functional Evaluation of the Heart and Lungs in Pulmonary Hypertension by Gated 2-[18F]-Fluoro-2-deoxy-D-glucose Positron Emission Tomography
por: Saygin, Didem, et al.
Publicado: (2017)

G-quadruplex induced stabilization by 2′-deoxy-2′-fluoro-d-arabinonucleic acids (2′F-ANA)
por: Peng, Chang Geng, et al.
Publicado: (2007)

(18)F-fluoro-2-deoxy-D-glucose positron emission tomography findings of neurolymphomatosis
por: Jung, Yun Hwa, et al.
Publicado: (2014)

Dynamic 2-deoxy-2[18F] fluoro-D-glucose PET/MRI in human renal allotransplant patients undergoing acute kidney injury
por: Pajenda, Sahra, et al.
Publicado: (2020)

Immuno-Imaging (PET/SPECT)–Quo Vadis?
por: Kramer, Carsten S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e3i6n8urodm5i4fv4ranr2n9ml